Exagen Inc. (XGN): Cash & Equivalents
$32.22M
As of 2025-12-31
$24.59M
As of 2026-06-30
-19.8%
3-year compound annual growth
-10.9%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $32.22M | +46.2% | 2026-03-10, Balance as of period end |
| 2024-12-31 | $22.04M | -39.6% | 2026-03-10, Balance as of period end |
| 2023-12-31 | $36.49M | -41.5% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $62.39M | -37.3% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $99.44M | +73.1% | 2023-03-20, Balance as of period end |
| 2020-12-31 | $57.45M | -20.3% | 2022-03-22, Balance as of period end |
| 2019-12-31 | $72.08M | +447.6% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $13.16M | n/a | 2020-03-25, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Exagen Inc. (XGN) | 2025-12-31 | $32.22M | +46.2% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $124.25M | +35.9% |
| Biodesix Inc (BDSX) | 2025-12-31 | $18.99M | -27.7% |
| CapForce Inc. (CFOR) | 2025-12-31 | $531.3K | -59.5% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $249.73M | +16.6% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $3.46M | -68.6% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $495.98M | +159.0% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $50.19M | -9.0% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $116.73M | -2.5% |
Compare XGN, PSNL, BDSX, CFOR side by side · Screen every company in Services-Medical Laboratories ↗